Phase
Condition
Heart Defect
Cardiovascular Disease
Anemia
Treatment
N/AClinical Study ID
Ages > 21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: All of the following must be present:
Acute myocardial infarction with presentation within 72 hours of randomization (acutemyocardial infarction is defined as ischemic-type chest discomfort lasting at least 30minutes associated with creatinine kinase MB (CKMB) or troponin >upper limit of normal [ULN])
Admission to CCU
Hematocrit .30 or less
Written, informed consent
Exclusion
Exclusion Criteria:
Inability or unwillingness to receive red cell transfusions
Active bleeding (overt blood loss accompanied by a decrease in hematocrit of at least 5% in the preceding 12 hours)
Receipt of red cell transfusion within 7 days of randomization
Prior severe transfusion reaction
Pregnancy
Imminent death
Decision to provide limited care
Age <21
Participation in another clinical trial in which blood transfusion is a requirement ora component of a primary or secondary endpoint
Previous participation in the CRIT Pilot
Study Design
Study Description
Connect with a study center
Washington Hospital Center
Washington, District of Columbia 20010
United StatesSite Not Available
Washington VA Medical Center
Washington, District of Columbia 20010
United StatesSite Not Available
Durham VA Medical Center
Durham, North Carolina
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.